Who has invested in Delix Therapeutics?

Comerica Bank are named among the investors backing Delix Therapeutics.

Delix Therapeutics Funding: $100M Raised, Series A (2022)

Delix Therapeutics funding overview

Delix Therapeutics is based in Concord, Massachusetts. Delix Therapeutics has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2022. The round record for Delix Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Comerica Bank.

Delix Therapeutics at a glance

Total raised: $100M
Latest round: Series A
Latest round date: January 2022
Headquarters: Concord, Massachusetts
Notable investors: Comerica Bank

Frequently asked about Delix Therapeutics funding

How much has Delix Therapeutics raised?: Delix Therapeutics has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Delix Therapeutics?: Comerica Bank are named among the investors backing Delix Therapeutics.
What was the latest Delix Therapeutics funding round?: The most recent disclosed round is a Series A, announced in January 2022.
Where is Delix Therapeutics based?: Delix Therapeutics is based in Concord, Massachusetts.
When did Delix Therapeutics last raise?: The last disclosed Delix Therapeutics round closed in January 2022 at Series A.

Delix Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Concord below to benchmark round size and investor mix.

Delix Therapeutics Funding: $100M Raised, Series A (2022)

Delix Therapeutics funding overview

Delix Therapeutics at a glance

Frequently asked about Delix Therapeutics funding

Companies related to Delix Therapeutics (40)

Browse related funding lists (3)